536 related articles for article (PubMed ID: 3882489)
1. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
Garvey WT; Olefsky JM; Griffin J; Hamman RF; Kolterman OG
Diabetes; 1985 Mar; 34(3):222-34. PubMed ID: 3882489
[TBL] [Abstract][Full Text] [Related]
2. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
[TBL] [Abstract][Full Text] [Related]
3. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
Mandarino LJ; Gerich JE
Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
[TBL] [Abstract][Full Text] [Related]
4. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.
Kolterman OG; Gray RS; Shapiro G; Scarlett JA; Griffin J; Olefsky JM
Diabetes; 1984 Apr; 33(4):346-54. PubMed ID: 6423429
[TBL] [Abstract][Full Text] [Related]
5. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
Garvey WT; Revers RR; Kolterman OG; Rubenstein AH; Olefsky JM
J Clin Endocrinol Metab; 1985 Mar; 60(3):559-68. PubMed ID: 3882736
[TBL] [Abstract][Full Text] [Related]
6. Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus.
Scarlett JA; Kolterman OG; Ciaraldi TP; Kao M; Olefsky JM
J Clin Endocrinol Metab; 1983 Jun; 56(6):1195-201. PubMed ID: 6341390
[TBL] [Abstract][Full Text] [Related]
7. The effects of superphysiologic hyperinsulinemia on glucose and lipid metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus (NIDDM).
Osei K
Diabetes Res Clin Pract; 1992 Sep; 17(3):169-82. PubMed ID: 1425156
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of insulin resistance in aging.
Fink RI; Kolterman OG; Griffin J; Olefsky JM
J Clin Invest; 1983 Jun; 71(6):1523-35. PubMed ID: 6345584
[TBL] [Abstract][Full Text] [Related]
9. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Baron AD; Schaeffer L; Shragg P; Kolterman OG
Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
[TBL] [Abstract][Full Text] [Related]
10. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
Kolterman OG; Gray RS; Griffin J; Burstein P; Insel J; Scarlett JA; Olefsky JM
J Clin Invest; 1981 Oct; 68(4):957-69. PubMed ID: 7287908
[TBL] [Abstract][Full Text] [Related]
11. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
12. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
Gumbiner B; Polonsky KS; Beltz WF; Griver K; Wallace P; Brechtel G; Henry RR
J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
[TBL] [Abstract][Full Text] [Related]
13. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
Henry RR; Brechtel G; Griver K
J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
[TBL] [Abstract][Full Text] [Related]
14. Assessment of hepatic insulin action in obese type 2 diabetic patients.
Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
[TBL] [Abstract][Full Text] [Related]
15. Insulin action during pregnancy. Studies with the euglycemic clamp technique.
Ryan EA; O'Sullivan MJ; Skyler JS
Diabetes; 1985 Apr; 34(4):380-9. PubMed ID: 3882502
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
Kolterman OG; Insel J; Saekow M; Olefsky JM
J Clin Invest; 1980 Jun; 65(6):1272-84. PubMed ID: 6997333
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro characterization of insulin resistance in three cases of lipoatrophic diabetes.
Robert JJ; Magre J; Reynet C; Darmaun D; Picard J; Capeau J
Diabete Metab; 1990; 16(3):240-7. PubMed ID: 2210020
[TBL] [Abstract][Full Text] [Related]
18. Effects of glyburide on in vivo insulin-mediated glucose disposal.
Simonson DC
Am J Med; 1990 Aug; 89(2A):44S-50S; discussion 51S-53S. PubMed ID: 2117389
[TBL] [Abstract][Full Text] [Related]
19. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
[TBL] [Abstract][Full Text] [Related]
20. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]